radiolabeled PDGFR-P1 peptide (University of Heidelberg)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameradiolabeled PDGFR-P1 peptide (University of Heidelberg)

Drug Alias NameN/A

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionPlatelet-derived growth factor receptor beta modulatorsCD276 antigen modulators

TargetsPlatelet-derived growth factor receptor betaCD276 antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHeidelberg University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHeidelberg University

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A